Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Novo Holding

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$126M
Portfolio companies 2
Rounds per year 0.14
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees Soon

Areas of investment

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
Summary

Novo Holding appeared to be the Corporate Investor, which was created in 1999. The venture was found in Europe in Sweden. The main office of represented Corporate Investor is situated in the Lund.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Harmony Biosciences, Spruce Biosciences.

The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Vivo Capital, Valor Equity Partners. In the next rounds fund is usually obtained by CRG L.P..

The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017. Deals in the range of more than 100 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Novo Holding:
Typical Co-investors
Novo Holding is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Novo Holding:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Baltisches Haus -
Brooks Brothers New York, New York, United States
China Pacific Insurance China, Shanghai
Delta Capital Management Nashville, Tennessee, United States
Dr. Max Iann Invest -
GaiaX Makati, Manila, Philippines
IAG Firemark Ventures Australia, New South Wales, Surry Hills
John Bendheim Enterprises -
Junfa Group China, Kunming, Yunnan
KSVFinland -
Last Call Capital -
Mando Coperation -
Marathon Venture Partners China, Shanghai
Mitsubishi Corporation Fashion Japan, Tokyo
NEM Ventures -
NEXT Frontier Capital Bozeman, Montana, United States
Reliance Venture Asset Management India, Maharashtra, Mumbai
Schurz Communications Indiana, Mishawaka, United States
Shoe Investments -
Xinjiang Buttonwood Equity Investment China, Ürümqi, Xinjiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Spruce Biosciences

Biopharma
Biotechnology
Health Care
Pharmaceutical
$88M20 Feb 2020 San Francisco, California, United States

Spruce Biosciences

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M02 Jan 2016 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Novo Holding?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 126M
Rounds per year 0.14
Peak activity year 2017
Lead investments 0
Follow on index 0.33
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Spruce Biosciences

Biopharma
Biotechnology
Health Care
Pharmaceutical
$88M20 Feb 2020 San Francisco, California, United States

Spruce Biosciences

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M02 Jan 2016 San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: